Three out of four U.S. adults support the use of emerging technologies that estimate a future child's likelihood of developing health conditions influenced by multiple genes—such as diabetes, heart ...

Three out of four U.S. adults support the use of emerging technologies that estimate a future child's likelihood of developing health conditions influenced by multiple genes - such as diabetes, heart ...

Justin Schleede is the executive lab director at Herasight, a company that screens embryos for health risks and traits such as height, longevity and IQ. (Kate Medley for NPR) Get the latest on the ...

Survey reveals nearly three-quarters of U.S. adults support using emerging technology to screen embryos during IVF for risk of developing certain health conditions or traits that arise from more than ...

Prospective parents can now pick embryos based on risk predictions for thousands of diseases and odds for specific traits. But should they? These companies help parents try to pick their babies' ...